stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Billiontoone IncBLLN
$101.593.39%-3.56

Billiontoone Inc (BLLN)

Billiontoone Inc stock is traded at $101.59, with a volume of 41,579. It is down -3.39% in the last 24 hours and up +3.54% over the past month. BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Previous Close:
$105.15
Open:
$105.06
24h Volume:
41,579
Relative Volume:
0.05
Market Cap:
$4.85B
Revenue:
$354.54M
Net Income/Loss:
$23.65M
P/E Ratio:
219.56
EPS:
$0.4627
Net Cash Flow:
-
1W Performance:
-11.62%
1M Performance:
+3.54%
6M Performance:
+22.95%
1Y Performance:
+12.88%
1-Day Range:
$100.53$105.06
1-Week Range:
$100.53$115.44
52-Week Range:
$61.96$150.44

Billiontoone Inc Stock (BLLN) Company Profile

Name
Billiontoone Inc
Phone
650-460-2551
Address
1035 O'BRIEN DRIVE, MENLO PARK, USA
Employee
713
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
BLLN's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Billiontoone Inc Stock (BLLN) Financials Data

Similar to BLLN